The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma (Q78206933)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma |
scientific article published on 01 August 1999 |
Statements
The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma (English)
Miknyoczki SJ
Chang H
Klein-Szanto A
Dionne CA